MTVA Latest Press Releases

-- October 28, 2026 --

MetaVia to Present Phase 1 Clinical Trial Data for DA-1726 in Oral Presentation at the Precision Liver Symposium 2026 PRNewswire 8:31 AM

-- October 13, 2026 --

MetaVia Appoints Seasoned Clinical Development Executive Sarah Browne, M.D., as Chief Medical Officer PRNewswire 8:31 AM

-- September 9, 2026 --

MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction PRNewswire 8:01 AM

-- August 6, 2026 --

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update PRNewswire 4:05 PM

-- July 9, 2026 --

MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity PRNewswire 8:31 AM

-- June 26, 2026 --

Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing Globe Newswire 8:35 AM

-- June 23, 2026 --

Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th Globe Newswire 8:35 AM

-- June 17, 2026 --

MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum PRNewswire 8:31 AM

-- June 10, 2026 --

Presenting on Emerging Growth Conference 93 Day 2 on June 11; Register to live stream Globe Newswire 7:00 AM

-- June 9, 2026 --

Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream Globe Newswire 7:00 AM

BioStem Technologies Announces Appointment of Three New Members to its Board of Directors Globe Newswire 7:00 AM

-- June 8, 2026 --

MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential PRNewswire 8:31 AM

-- June 4, 2026 --

MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference PRNewswire 8:31 AM

Market Data Delayed 15 Minutes